Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits QuantWave's Price Target, Generating 27.35% Profit

May 03, 2023
ELI LILLY AND COMPANY (NYSE: LLY) investors recently experienced a substantial gain as the stock successfully achieved QuantWave's price target forecast, resulting in a profit of 27.35%. The forecast signal was emitted on February 7, 2023, when the stock was trading at $332.19, with a predicted long direction indicated. The target price of $423.05 was reached on May 3, 2023.

The achievement of this forecast showcases the accuracy and effectiveness of QuantWave's analytics in predicting stock movements. Several factors may have contributed to ELI LILLY AND COMPANY's price growth, including positive earnings reports, strategic partnerships, and advancements in its product pipeline. Investors who acted on the forecast signal would have capitalized on this opportunity for significant gains.

QuantWave is an automated forecasting platform that provides users with predictions for various stocks, presenting valuable opportunities for profits in the financial markets. For individuals interested in exploring QuantWave's investment strategy further, QuantSchool offers comprehensive educational resources that outline the key principles for generating consistent income utilizing the forecasting system.

Overall, the successful forecast for ELI LILLY AND COMPANY exemplifies the potential benefits of leveraging QuantWave's predictive capabilities for informed investment decisions in the ever-changing stock market landscape.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target, Generating 18.65% Profit for QuantWave Users  ~1 min.

ELI LILLY AND COMPANY's stock recently reached the price target forecasted by QuantWave on 2024-08-06. The forecast signal indicated a short position, with the stock priced at 786.06 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Short Price Target Forecast Resulting in 19.15% Profit for QuantWave Users  ~2 min.

ELI LILLY AND COMPANY (LLY) investors recently saw the stock hitting a short price target forecast set by QuantWave, resulting in a substantial profit of 19.15%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Resulting in 19.55% Profit - QuantWave Success  ~1 min.

ELI LILLY AND COMPANY stock has successfully reached the price target as forecasted by QuantWave, resulting in a profitable 19.55% gain for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 22.51% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved its forecasted price target as predicted by QuantWave, a leading automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Price Target with 22.13% Profit on QuantWave Platform  ~2 min.

ELI LILLY AND COMPANY (LLY) recently achieved the forecast price target on the QuantWave platform, resulting in a remarkable 22.13% profit for investors who followed the short signal....


LLYAugust 1, 2025Eli Lilly and Company Completes Acquisition of Verve Therapeutics, Advancing One-Time Treatments for High Cardiovascular Risk  ~1 min.

Eli Lilly and Company has announced the successful completion of its acquisition of Verve Therapeutics, a move that will help advance innovative one-time treatments for individuals with high cardiovascular risk. This strategic decision showcases the company's commitment to revolutionizing the healthcare industry and improving patient outcomes. Investors are eagerly watching as Eli Lilly continues ...


LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....


LLYAugust 8, 2023ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 32.11% Profit: QuantWave Analysis  ~2 min.

ELI LILLY AND COMPANY (LLY) investors reaped substantial rewards as the stock successfully achieved the price target forecast set by QuantWave, resulting in an impressive profit of 32.11%....


CRMDecember 18, 2023SALESFORCE, INC. Stock Hits QuantWave's Price Target Forecast with 22.2% Profit  ~1 min.

SALESFORCE, INC. (CRM) investors rejoiced as QuantWave's forecast signal successfully reached its price target, delivering a substantial 22.2% profit....


FORDJuly 28, 2025QuantWave Hits Bullseye with 79.68% Profit on FORWARD INDUSTRIES, INC. Forecast  ~2 min.

In a remarkable display of accuracy, QuantWave's automated forecasting platform successfully predicted a long position for FORWARD INDUSTRIES, INC. with a profit of 79.68%....


TRPJuly 26, 2024TC ENERGY CORPORATION Hits Price Target Forecast on QuantWave with 15.79% Profit  ~1 min.

TC ENERGY CORPORATION has successfully achieved the price target forecast set by QuantWave, with a profit of 15.79%....


SLBSeptember 6, 2023QuantWave Forecast Successfully Hits Price Target for SCHLUMBERGER LIMITED, Generating Profit of 74.43%  ~1 min.

On June 30, 2022, QuantWave issued a long signal for SCHLUMBERGER LIMITED with a price of $33.43. Fast forward to September 6, 2023, the stock reached the predicted target price of $58....